Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
Sponsor: Columbia University
Postoperative Insomnia · Postoperative Delirium
United States
- ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerActive Not Recruiting
Sponsor: Rahul Aggarwal
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Metastatic Prostate Small Cell Carcinoma · Stage IV Prostate Cancer AJCC v8
United States
Sponsor: National Human Genome Research Institute (NHGRI)
Familial Mediterranean Fever (FMF) · Autoinflammation · Periodic Fever · Fever
United States
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Canada +7 more
- Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Hypertension, Pulmonary
United States, Belgium, Canada, France, Germany +7 more
Sponsor: Merck Sharp & Dohme LLC
Metastatic Castration-resistant Prostate Cancer (mCRPC) · Prostatic Neoplasms
United States, Australia, Brazil, Canada, Chile +34 more
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Brazil +19 more
- Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory LymphomasActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Lymphoma · Relapsed · Refractory
United States
Sponsor: University of Colorado, Denver
Microsatellite Stable Metastatic Colorectal Cancer
United States
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasm Malignant
United States, Brazil, Chile, China, Germany +6 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Cervical Cancer
United States, Belgium, Czechia, Denmark, Ireland +5 more
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Exocrine Pancreatic Cancer · Carcinoma, Squamous Cell of Head and Neck
United States, Canada, France, Germany, Italy +2 more
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +26 more
- A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Renal Cell Carcinoma
United States, Australia, Israel
- A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Active Not Recruiting
Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Advanced Solid Tumors · Solid Tumor · Solid Carcinoma · Solid Tumor, Adult
Sponsor: Fred Hutchinson Cancer Center
Human Papillomavirus-Related Carcinoma
United States
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Australia, Belgium, Canada, Denmark +17 more
Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Crohn Disease
United States, Australia, Belgium, Canada, Czechia +3 more
Sponsor: Memorial Sloan Kettering Cancer Center
Glioma
United States
Sponsor: NovoCure GmbH
Glioblastoma
United States, Canada, Czechia, France, Germany +7 more
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma (ESCC) · Gastroesophageal Junction Carcinoma (GEJC) · Esophageal Adenocarcinoma (EAC)
United States, Argentina, Belgium, Brazil, Canada +22 more
Sponsor: Daiichi Sankyo
Non-small Cell Lung Cancer
United States, Argentina, Belgium, Brazil, Chile +18 more
- Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian CancerActive Not Recruiting
Sponsor: Alexander B Olawaiye, MD
Ovarian Cancer
United States
- A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Cancer · Non-Small Cell Lung Cancer
United States, China, Germany, Guatemala, Japan +7 more
- Pembrolizumab In Central Nervous System MetastasesActive Not Recruiting
Sponsor: Massachusetts General Hospital
Brain Metastases
United States